Literature DB >> 9196183

Serological determination of hepatitis C virus genotype: comparison with a standardized genotyping assay.

J M Pawlotsky1, L Prescott, P Simmonds, C Pellet, P Laurent-Puig, C Labonne, F Darthuy, J Remire, J Duval, C Buffet, J P Etienne, D Dhumeaux, E Dussaix.   

Abstract

In patients with chronic hepatitis C, determination of hepatitis C virus (HCV) genotype could be routinely run in the future to tailor treatment schedules. The suitabilities of two versions of a serological, so-called serotyping assay (Murex HCV Serotyping Assay version 1-3 [SA1-3] and Murex HCV Serotyping Assay version 1-6 [SA1-6]; Murex Diagnostics Ltd.), based on the detection of genotype-specific antibodies directed to epitopes encoded by the NS4 region of the genome, for the routine determination of HCV genotypes were studied. The results were compared with those of a molecular biology-based genotyping method (HCV Line Probe Assay [INNO-LiPA HCV]; Innogenetics S.A.), based on hybridization of PCR products onto genotype-specific probes designed in the 5' noncoding region of the genome, obtained with pretreatment serum samples from 88 patients with chronic hepatitis C eligible for interferon therapy. Definitive genotyping was performed by sequence analysis of three regions of the viral genome in all samples with discrepant typing results found among at least two of the three assays studied. In all instances, sequence analysis confirmed the result of the INNO-LiPA HCV test. The sensitivity of SA1-3 was 75% relative to the results obtained by the genotyping assay. The results were concordant with those of genotyping for 92% of the samples typeable by SA1-3. The sensitivity of SA1-6 was 89% relative to the results obtained by the genotyping assay. The results were concordant with those of genotyping for 94% of the samples typeable by SA1-6. Overall, SA1-6 had increased sensitivity relative to SA1-3 but remained less sensitive than the genotyping assay on the basis of PCR amplification of HCV RNA. Cross-reactivities between different HCV genotypes could be responsible for the mistyping of 8 (SA1-3) and 6% (SA1-6) of the samples. Subtyping of 1a and 1b is still not possible with the existing peptides, but discriminating between subtypes may not be necessary for routine use.

Entities:  

Mesh:

Year:  1997        PMID: 9196183      PMCID: PMC229831          DOI: 10.1128/jcm.35.7.1734-1739.1997

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  24 in total

1.  Significance of specific antibody assay for genotyping of hepatitis C virus.

Authors:  T Tanaka; K Tsukiyama-Kohara; K Yamaguchi; S Yagi; S Tanaka; A Hasegawa; Y Ohta; N Hattori; M Kohara
Journal:  Hepatology       Date:  1994-06       Impact factor: 17.425

2.  Are hepatitis C virus genotypes 1a and 1b so different?

Authors:  J M Pawlotsky; F Roudot-Thoraval; A Bastie; C Pellet; J Duval; D Dhumeaux
Journal:  Hepatology       Date:  1996-05       Impact factor: 17.425

3.  Influence of hepatitis C virus (HCV) genotypes on HCV recombinant immunoblot assay patterns.

Authors:  J M Pawlotsky; F Roudot-Thoraval; C Pellet; P Aumont; F Darthuy; J Remire; J Duval; D Dhumeaux
Journal:  J Clin Microbiol       Date:  1995-05       Impact factor: 5.948

4.  Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantation.

Authors:  C Féray; M Gigou; D Samuel; V Paradis; S Mishiro; G Maertens; M Reynés; H Okamoto; H Bismuth; C Bréchot
Journal:  Gastroenterology       Date:  1995-04       Impact factor: 22.682

5.  Sequence analysis of the core gene of 14 hepatitis C virus genotypes.

Authors:  J Bukh; R H Purcell; R H Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-16       Impact factor: 11.205

6.  Relationship between hepatitis C virus genotypes and sources of infection in patients with chronic hepatitis C.

Authors:  J M Pawlotsky; L Tsakiris; F Roudot-Thoraval; C Pellet; L Stuyver; J Duval; D Dhumeaux
Journal:  J Infect Dis       Date:  1995-06       Impact factor: 5.226

7.  Evaluation of a novel serotyping system for hepatitis C virus: strong correlation with standard genotyping methodologies.

Authors:  V Dixit; S Quan; P Martin; D Larson; M Brezina; R DiNello; K Sra; J Y Lau; D Chien; J Kolberg
Journal:  J Clin Microbiol       Date:  1995-11       Impact factor: 5.948

8.  Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region.

Authors:  P Simmonds; E C Holmes; T A Cha; S W Chan; F McOmish; B Irvine; E Beall; P L Yap; J Kolberg; M S Urdea
Journal:  J Gen Virol       Date:  1993-11       Impact factor: 3.891

9.  Investigation of the pattern of hepatitis C virus sequence diversity in different geographical regions: implications for virus classification. The International HCV Collaborative Study Group.

Authors:  J Mellor; E C Holmes; L M Jarvis; P L Yap; P Simmonds
Journal:  J Gen Virol       Date:  1995-10       Impact factor: 3.891

10.  Hepatitis C virus genotyping by means of 5'-UR/core line probe assays and molecular analysis of untypeable samples.

Authors:  L Stuyver; A Wyseur; W van Arnhem; F Lunel; P Laurent-Puig; J M Pawlotsky; B Kleter; L Bassit; J Nkengasong; L J van Doorn
Journal:  Virus Res       Date:  1995-10       Impact factor: 3.303

View more
  15 in total

Review 1.  Laboratory assays for diagnosis and management of hepatitis C virus infection.

Authors:  Sandra S Richter
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

Review 2.  Serodiagnosis for tumor viruses.

Authors:  Brian J Morrison; Nazzarena Labo; Wendell J Miley; Denise Whitby
Journal:  Semin Oncol       Date:  2014-12-31       Impact factor: 4.929

Review 3.  KASL clinical practice guidelines: management of hepatitis C.

Authors: 
Journal:  Clin Mol Hepatol       Date:  2016-03-28

Review 4.  Hepatitis C virus: Virology, diagnosis and treatment.

Authors:  Hui-Chun Li; Shih-Yen Lo
Journal:  World J Hepatol       Date:  2015-06-08

5.  Serological determination of hepatitis C virus subtypes 1a, 1b, 2a, 2b, 3a, and 4a by a recombinant immunoblot assay.

Authors:  M Schröter; H H Feucht; P Schäfer; B Zöllner; R Laufs
Journal:  J Clin Microbiol       Date:  1999-08       Impact factor: 5.948

6.  Genotyping of hepatitis C virus types 1, 2, 3, and 4 by a one-step LightCycler method using three different pairs of hybridization probes.

Authors:  Matthias Schröter; Bernhard Zöllner; Peter Schäfer; Olfert Landt; Ulrich Lass; Rainer Laufs; Heinz-Hubert Feucht
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

7.  Tim-3 expression on PD-1+ HCV-specific human CTLs is associated with viral persistence, and its blockade restores hepatocyte-directed in vitro cytotoxicity.

Authors:  Rachel H McMahan; Lucy Golden-Mason; Michael I Nishimura; Brian J McMahon; Michael Kemper; Todd M Allen; David R Gretch; Hugo R Rosen
Journal:  J Clin Invest       Date:  2010-11-15       Impact factor: 14.808

8.  Algorithmic approach to high-throughput molecular screening for alpha interferon-resistant genotypes in hepatitis C patients.

Authors:  S Sreevatsan; J B Bookout; F M Ringpis; M R Pottathil; D J Marshall; M De Arruda; C Murvine; L Fors; R M Pottathil; R R Barathur
Journal:  J Clin Microbiol       Date:  1998-07       Impact factor: 5.948

Review 9.  Hepatitis C virus: virology, diagnosis and management of antiviral therapy.

Authors:  Stéphane Chevaliez; Jean-Michel Pawlotsky
Journal:  World J Gastroenterol       Date:  2007-05-07       Impact factor: 5.742

10.  High prevalence of hepatitis C virus type 5 in central France evidenced by a prospective study from 1996 to 2002.

Authors:  Cécile Henquell; Carole Cartau; Armand Abergel; Henri Laurichesse; Christel Regagnon; Christophe De Champs; Jean-Luc Bailly; Hélène Peigue-Lafeuille
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.